The heart failure pandemic: The clinical and economic burden in Greece

P Stafylas1, D Farmakis2, G Kourlaba3

  • 1University of Macedonia, Thessaloniki, Greece.

Insights

Heart failure (HF) in Greece has high annual mortality and rehospitalization rates, especially for hospitalized patients. This disease imposes a substantial economic burden, with most costs attributed to inpatient care, highlighting the need for better management strategies.

Area of Science:

  • Cardiology
  • Public Health
  • Health Economics

Background:

  • Heart failure (HF) poses a significant health challenge globally and in Greece.
  • Understanding the epidemiological and clinical profile of HF patients is crucial for effective management.
  • Assessing the economic burden of HF is vital for healthcare resource allocation.

Purpose of the Study:

  • To determine the epidemiological and clinical characteristics of heart failure patients in Greece.
  • To evaluate the economic burden and cost distribution associated with heart failure management.
  • To provide insights for improving disease management and reducing hospital admissions.

Main Methods:

  • A prospective, observational survey (ESC HF Pilot Survey) conducted across eight Greek cardiology centers.
  • Inclusion of 307 heart failure patients (177 hospitalized, 130 outpatients) monitored for 12 months.
  • Collection of clinical, epidemiological, mortality, hospitalization, and healthcare resource utilization data; economic evaluation from a social security perspective.

Main Results:

  • Annual mortality rates were 24.3% for hospitalized vs. 7.7% for outpatients (P<0.001).
  • Annual rehospitalization rates were 42.9% for hospitalized vs. 19.2% for outpatients (P<0.001).
  • Mean annual economic burden per HF patient was €4411±4764, with ~2/3 due to inpatient care.

Conclusions:

  • Despite advances, significant mortality and rehospitalization persist in HF patients, particularly those hospitalized.
  • Kidney dysfunction, S3 gallop, and higher NYHA class are associated with worse survival.
  • Effective drug treatments and efficient disease management programs are needed to reduce hospital admissions and associated costs.
Abstract

Related Concept Videos

Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
759
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.3K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
1.1K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
566
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
603
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
621